Agoracom Blog Home

Posts Tagged ‘MMJ’

« Older Entries
Newer Entries »

Namaste $N.ca $NXTTF signs Master Services Agreement with Australian-based YPB to Provide consumer confidence solutions to its customers $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:36 AM on Wednesday, June 27th, 2018

  • Announced signing of a Master Services Agreement with YPB Group Ltd. (“YPB”)(ASX: YPB), an Australian based product verification and customer engagement company
  • Namaste plans to introduce YPB’s solutions across its network of manufacturers and to Canadian Licensed Producers to bring certainty of authenticity and supply chain transparency to the entire legal cannabis industry globally

VANCOUVER, June 27, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce signing of a Master Services Agreement (the “Agreement”) with YPB Group Ltd. (“YPB”)(ASX: YPB), an Australian based product verification and customer engagement company. Namaste has identified the need for its global customers to have confidence in the products they are purchasing, and for vendors to have access to granular data on their end-users. As such, Namaste plans to introduce YPB’s solutions across its network of manufacturers and to Canadian Licensed Producers to bring certainty of authenticity and supply chain transparency to the entire legal cannabis industry globally. This coalition furthers Namaste’s agenda in providing leading technology platforms for its global marketplace and in enhancing the user’s experience for its customers.

Namaste is the world’s largest and most comprehensive cannabis-focused e-commerce platform with 32 sites in 20 countries and over 600,000 monthly visits to their e-commerce sites with a database of approximately 1.5 million users. Their fully integrated e-commerce network spans across the globe offering everything from rolling papers to vaporizers. In Canada, Namaste has developed the country’s first telemedicine app, available on iPhone and Android devices which allows patients to connect to doctors or nurse practitioners and have access to a wide range of high-quality cannabis products and services. The shared strategy of this Agreement is to leverage Namaste’s market position with the objective that all vendors on its platform across the entire cannabis supply chain will adopt this technology and mark every product with YPB ProtectCodes to help protect consumers by ensuring the products and services they are purchasing are safe and reliable.

Sean Dollinger, President, and CEO of Namaste comments: “Our extensive tender process identified Australian-based company YPB as being able to deliver the most sophisticated forensic level anti-counterfeit security for brand protection. We are confident YPB’s Secure Supply Chain tracking will enhance trust in the legitimacy and integrity of the vast range of products and services being sold throughout the industry. Namaste has spent years building strong, trusted relationships with vendors in the industry many of whom suffer from having their products counterfeited and sold through unlicensed distributors. Through this partnership, Namaste offers an effective solution to further support our vaporizer and hardware vendors. Additionally, we believe this technology has the ability to revolutionize the sale of cannabis throughout the Canadian market, with the potential for global market penetration. We fully intend on leveraging our relationships with licensed producers with the hope of providing additional value to LP’s and their customers. As the market expands and becomes more competitive we expect to see an increased demand for the adoption and implementation of anti-counterfeit security to ensure all parties involved are adequately protected. We believe YPB is a leader in the space and we are excited to work alongside them to come up with unique solutions for the cannabis industry.

In the last five years, Founder and CEO of YPB, John Houston has seen a notable increase in the number of global eCommerce brands who are looking at how to protect consumers and brand value with YPB’s technology. It is predicted that by 2022, the value of the global counterfeit market will reach $US4.2 Trillion and 5.4 million jobs will be at risk. According to World Health Organization estimates, one million people die each year from counterfeit medicines. Counterfeit is a global issue and brands are increasingly needing to become smarter and look at ways to protect their customers from fakes to mitigate risk to their brand reputation.

The ability to engage directly with customers who have scanned a YPB protected product to confirm authenticity but have not purchased through a Namaste platform will also provide them with valuable market intelligence to know, understand and connect with a greater proportion of the cannabis community more effectively.

John Houston, YPB Executive Chairman comments: “Namaste is a smart, rapidly growing company with powerful competitive advantages and a unique central hub position in the legal cannabis industry. YPB could not find a better partner with whom to participate in the expected rapid growth of cannabis consumption. Namaste’s footprint offers YPB exceptional global access with ease of execution at low cost and its adoption of our technology is recognition of the power of product authenticity to build customer trust, relationships and numbers. This is YPB’s single biggest opportunity yet and we will work closely with Namaste to ensure conversion to real shareholder wealth. I’m also delighted to welcome Namaste onto our share register and the magnification of our mutual interests that it brings.”

ABOUT NAMSTE TECHNOLOGIES

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer pending receipt of a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

About YPB

Established in Australia in 2011 (listed on the ASX in 2014), YPB is at the centre of the global fight to protect the integrity of brands from commercial losses through highly advanced authentication solutions that enable brands to trigger customer engagement.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/June2018/27/c3887.html

Sean Dollinger, Chief Executive Officer, Direct: +1 (786) 389 9771, Email: [email protected] CNW Group 2018

Tags: , , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca $NXTTF signs Master Services Agreement with Australian-based YPB to Provide consumer confidence solutions to its customers $ATT.ca $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Senate passes #cannabis legalization bill in final vote #Canada $N.ca $NXTTF $TBP.ca $MCOA

Posted by AGORACOM-JC at 10:16 AM on Wednesday, June 20th, 2018
  • Senate has voted to pass Bill C-45, the government’s legislation to legalize cannabis, meaning that recreational marijuana will soon be legal across Canada
  • Some parliamentarians are calling it an “historic” moment in this country, while others are warning of the work left to be done: raising public awareness about the implications of this incoming major social policy change.

Rachel Aiello, Ottawa News Bureau Online Producer

Published Tuesday, June 19, 2018 4:21PM EDT

Last Updated Wednesday, June 20, 2018 9:45AM EDT

OTTAWA — The Senate has voted to pass Bill C-45, the government’s legislation to legalize cannabis, meaning that recreational marijuana will soon be legal across Canada.

Some parliamentarians are calling it an “historic” moment in this country, while others are warning of the work left to be done: raising public awareness about the implications of this incoming major social policy change.

After more than a year of intensive study in both the House and Senate, the bill cleared the final legislative hurdle Tuesday evening, passing by a vote of 52 to 29 with two abstentions from the Independent Senators from Quebec: Sen. Marie-Françoise Mégie and Sen. Rosa Galvez.

Complete coverage on CTVNews.ca

Sen. Claude Carignan, leader of the opposition in the Senate, speaks to reporters in the Senate foyer on Parliament Hill in Ottawa on Tuesday, June 19, 2018. THE CANADIAN PRESS/Justin Tang

The vote was on a motion from Sen. Peter Harder, the Government Representative in the Senate, to accept the government’s position on the Senate’s amendments and pass the bill as is. It was all that was left in a short round of legislative ping-pong spurred by the upper chamber amending the government legislation.

The House of Commons will be notified of the Senate’s decision. After that, all that is left will be Royal Assent to officially pass the bill and for the government to determine when the new law will come into force.

Leader of the Independent Senators Group Sen. Yuen Pau Woo told reporters after the vote that the mammoth study of Bill C-45 was “a bit of a stress test” for the increasingly Independent Senate.

He said now, the work will have to begin on implementing the legislation, and making sure Canadians understand what this new regime means.

“We are now moving where in the legalized industry we have the chance to push out the illicit elements, we have the chance to do research on cannabis, we have the chance to properly educate our young people on the harms of cannabis use, and all of this should be the focus of the whole country now,” Sen. Woo said.

The legislation — an electoral promise of Prime Minister Justin Trudeau and the Liberal Party –allows adults in Canada to legally possess and use small amounts of recreational cannabis. It sets out parameters around the production, possession, safety standards, distribution, and sale of the drug. It also creates new Criminal Code offences for selling marijuana to minors. The proposed federal law spells out that it will be illegal for anyone younger than 18 to buy pot, but allows for provinces and territories to set a higher minimum age.

In a tweet, Justice Minister Jody Wilson-Raybould, who was the bill’s sponsor, and first introduced the legislation in April 2017, said it was “an historic milestone for progressive policy in Canada.”

The federal government is expected to formally respond to the bill’s passage Wednesday morning in the House of Commons foyer.

Last week, the government announced it would be accepting most but not all of the Senate’s more than 40 proposed amendments to Bill C-45. Among the 13 amendments that the federal Liberals rejected were the proposal to allow the provinces and territories to ban home-grown marijuana, and a proposed change to prohibit pot producers from distributing branded merchandise.

Earlier in the evening, an attempt by Conservative Sen. Claude Carignan to insist on an amendment to let provinces ban marijuana home cultivation, failed.

Reacting to his effort to push back on the government’s rejection of the change, Carignan said his attempt was to give the provinces a right he believes they should have, in an effort to circumvent what is now likely: the matter winding up in court.

Senators spent much of Tuesday offering their final thoughts on the legislation, with some expressing disappointment and frustration over MPs not accepting the Senate’s changes, and raising remaining concerns with the legislation as it stands.

Others argued that the upper chamber had done its due diligence and that it was time to concede to the will of the elected House of Commons, and pass the legislation.

In calling the vote, Senate Speaker George Furey had a slip of the tongue and called “all those in flavour” instead of “all those in favour,” sending snickers through the chamber. “It’s getting late,” Sen. Furey said.

Speaking with reporters following the vote, Sen. Harder said he was finally pausing after the manoeuvrings and the procedural wrangling to acknowledge that after a very lengthy debate, Canada is on the cusp of legalization after nearly a century of prohibition.

“It is a step in the right direction and what we now need to do is to insure as we move forward in implementation, that everybody plays their role, that everybody understands the obligations that they have and uses the opportunity of the next number of weeks to inform themselves of what a legal cannabis market means for them, their family, their communities, and the opportunities and risks that it poses,” said Sen. Harder.

So is marijuana legal? No.

The bill still needs to receive Royal Assent, which is expected as soon as tomorrow. That is the final step — essentially the Crown approving the bill. It’s overseen by Canada’s representative, the Governor General.

Once it passes, the government is expected to declare the date that legalization will come into force and be applicable.

On CTV’s Question Period, parliamentary secretary and the federal government’s point-person on pot, Bill Blair said he expects the date to be some time this September.

That window of time between when the bill passes and when it becomes federal law is to allow for the provinces, territories, municipalities, police forces, and other stakeholders to make sure their piece of the pot pie is operating in accordance with the new rules.

Blair said the date they decide on will be informed by discussions with their provincial and territorial counterparts, which have been given the ability to set regulations in their jurisdictions as to how a legalized marijuana regime will operate.

What you need to know:

Many of the decisions around how legalized marijuana is sold and used will be up to the provinces and territories. Here is what you need to know about what will be allowed:

  • The federally mandated public possession limit of 30 grams of dried cannabis has been maintained across the country, with most jurisdictions opting to keep their legal marijuana-smoking ages in line with those for drinking alcohol.
  • Bill C-45 allows individuals to grow up to four marijuana plants per residence, though some provinces, like Manitoba and Quebec, plan to ban home cultivation.
  • Provincial and territorial plans vary widely on whether you’ll be able to smoke in public.
  • Provinces and territories also differ on whether pot shops will be publicly or privately owned. For those opting for publicly owned stores, these will be operated by provincial Crown corporations that sell liquor. In some cases, provinces have even created subsidiaries of these companies with names. Unless otherwise noted, these will be standalone stores wholly separate from those that sell alcohol.
  • While dried cannabis and cannabis oil — both of which will be sold in 2018 — can be used to make edible products at home, the federal government has said that packaged edible products won’t be commercially available.

For a comprehensive rundown of how each province is approaching legalized marijuana, click here.

Outcome of drug-impaired driving bill pending

Bill C-45 was introduced alongside Bill C-46 which specifically deals with impaired driving. The government has hoped throughout the process that the two bills would pass in close succession.

This legislation proposes changes to the impaired driving laws to give police new powers to conduct roadside intoxication tests, including oral fluid drug tests, and would make it illegal to drive within two hours of being over the legal limit.

However, the Senate amended Bill C-46 to remove the provision that allowed police to conduct random roadside alcohol tests. The Senate also sought to legally downgrade impaired driving offences so that they are not classified as “serious criminality” in order to protect foreign nationals and permanent residents from losing their statuses or becoming inadmissible to Canada after such a conviction.

On Monday, the government gave notice of its position on the Senate changes, stating that it “respectfully disagrees” with these two changes. However, in the motion the government indicates it is willing to accept a handful of other Senate amendments to the legislation.

The House has yet to send this message back to the Senate but once that occurs, Bill C-46 is in for a similar final debate and vote, as seen with Bill C-45, where senators will have to decide whether they insist, or accept and pass the bill.

The House of Commons is scheduled to adjourn for the summer on Friday, June 22, but the Senate is set to sit for a week longer. There is always the potential of an early adjournment, or the opportunity to sit longer in exceptional circumstances.

Source: https://www.ctvnews.ca/politics/senate-passes-cannabis-legalization-bill-in-final-vote-1.3980234

Tags: , , , ,
Posted in All Recent Posts, Marijuana Company of America, Namaste Technologies Inc. | Comments Off on Senate passes #cannabis legalization bill in final vote #Canada $N.ca $NXTTF $TBP.ca $MCOA

Marijuana Company of America $MCOA Launches New CBD-Infused Cosmetic Product hempSMART(TM) Face $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:34 AM on Tuesday, June 19th, 2018

15233 mcoa

  • Announced that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART™ Face
  • Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant

Escondido, California–(June 19, 2018) – Marijuana Company of America, Inc. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART™ Face.

Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant. The newly developed hempSMART™ topical is a nourishing facial moisturizer that combines CBD oil with a unique blend of ayurvedic herbs and botanicals that is designed to refresh, replenish, and restore your skin cells on your face.

The innovative new formula is rich in Omega 3, 6, 7 and 9, along with naturally occurring ceramides and contains synergistic ingredients such as Organic Aloe, Sabi Inchi Oil, Argan Kernel Oil, Macademia Seed Oil, Rose Hip Seed Oil, Pomegranate Seed Oil, Tulsi, Turmeric Oil, Frankinsense, Ashwaganda, Sweet Potato Root Extract, Coconut Oil, and Sea Buckthorn Oil.

MCOA’s CEO, Donald Steinberg, commented, “Our team is excited to announce the expansion of the hempSMART™ brand into the world of cosmetic products. HempSMART™ will continue to build upon our already established and unique formulations to provide our customers and affiliates with the tools needed to succeed in the wellness industry.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tags: , , , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks | Comments Off on Marijuana Company of America $MCOA Launches New CBD-Infused Cosmetic Product hempSMART(TM) Face $AERO $CBDS $CGRW $APH.ca $GBLX

Tetra Bio-Pharma $TBP.ca Adds a New Leader for its Commercial Operations $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:19 AM on Tuesday, June 19th, 2018

Logo tetrabiopharma rgb web

  • Announced that Mr. Richard Giguere has been hired as Executive Vice-President, Commercial Operations
  • He will be responsible for the commercial sales and operations of Tetra Natural Health and Tetra Veterinary Health

Tetra Natural Health and Tetra Veterinary Health

ORLEANS, Ontario, June 19, 2018 – Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), is pleased to announce that Mr. Richard Giguere has been hired as Executive Vice-President, Commercial Operations. He will be responsible for the commercial sales and operations of Tetra Natural Health and Tetra Veterinary Health.

Richard has more than 20 years’ experience in sales and marketing in the pharmaceutical industry from coast to coast. During his career, he has held various business development, management and negotiation positions and launched several new products on the Canadian market. He has worked for various pharmaceutical companies in sectors such as generics, branded products and medical devices. He has also worked with OTC, natural products and original medications. Richard is recognized for his deep ethical sense, respect of others and talent for developing long-term business relationships through flexibility and efficiency. In the past 10 years, he was also a board member at the companies for which he worked.

“We’re very proud to add Richard Giguere to our senior management team. His vast experience in the sales and marketing of OTC, natural health products and original medications in the pharmaceutical industry across Canada will help drive the execution of our corporate strategy for our Tetra Natural Health and Tetra Veterinary Health divisions,” says Guy Chamberland, Interim Chief Executive Officer of Tetra Bio-Pharma.

Richard Giguere’s arrival is perfectly aligned with Tetra Bio-Pharma’s decision to restructure its corporation by commercial markets. While Tetra Bio-Pharma will be dedicated to pharmaceutical development and commercialization of cannabinoid-based prescription drugs and treatments, Tetra Natural Health will develop and sell cannabinoid-based OTC (self-care) products to leverage the post-legalization market and Tetra Veterinary Health will focus on commercialization of cannabinoid-based products for the pet product market.

“I am honored to be able to play an active role in growing both the Tetra Natural Health and Tetra Veterinary Health divisions,” says Richard Giguere, EVP, Commercial Operations. “Tetra has a sound business model, and there are significant opportunities for us to grow our two commercial divisions. I am committed to making the best business and commercial decisions to accelerate the development of these huge potential markets for our cannabinoid-based products.”

As a result of this senior management change, Anne-Sophie Courtois left the corporation thereby terminating her role as Vice President, Marketing and Communications.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
More information at: www.tetrabiopharma.com

For further information, please contact Tetra Bio-Pharma Inc.
Guy Chamberland, Interim Chief Executive Officer
[email protected]

For investors information, please contact:
[email protected]
(438) 504-5784

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514 840 7990 M: 1 514 232 1556

Tags: , , , ,
Posted in Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma $TBP.ca Adds a New Leader for its Commercial Operations $AERO $CBDS $CGRW $APH.ca $GBLX

Namaste $N.ca announces signing of 15% equity acquisition of same-day #cannabis delivery platform, Pineapple Express Delivery Inc. $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 10:27 AM on Wednesday, June 13th, 2018

Namaste large new

  • Further to its April 25th, 2018 announcement of a Letter of Intent with Pineapple Express Delivery Inc., the Company has signed a Subscription Agreement
  • To acquire 15% of the share capital of Pineapple Express Delivery Inc. for  $1,000,000

VANCOUVER, June 13, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to its April 25th, 2018 announcement of a Letter of Intent with Pineapple Express Delivery Inc., the Company has signed a Subscription Agreement (the “Agreement”) to acquire 15% of the share capital of Pineapple Express Delivery Inc. for  $1,000,000. Additionally, Namaste is pleased to announce that Pineapple Express Delivery Inc. has secured a Courier Services Agreement with Ample Organics, Canada’s leading seed-to-sale software platform, for same-day cannabis delivery. Both transactions validate Namaste’s position as a leader in cannabis focused technology platforms, and further demonstrate Namaste’s ability to identify these value-added services aimed at enhancing the user experience. Namaste is optimistic about its equity investment in Pineapple Express Delivery Inc. and expects to see an immediate impact to the overall business operation.

Terms of the Agreement:

  • Namaste’s investment of $1,000,000 will be comprised of $850,000 in cash and $150,000 in Namaste common stock issued at a deemed price determined by Namaste’s 5-day VWAP as of June 15, 2018, subject to approval by the TSX Venture Exchange.
  • The $850,000 cash component of the investment will be paid over 12 monthly instalments to be used in accordance with an agreed use of proceeds.
  • Namaste has a right of first refusal to acquire an additional 10% interest in Pineapple Express Delivery Inc. for $1,200,000 for 14 months following the closing date.
  • Namaste will issue 150,000 options to purchase common shares pursuant to a consulting agreement entered into between Namaste and a principal of Pineapple Express Delivery Inc.

Namaste plans to work directly with Pineapple Express Delivery Inc. and Ample Organics to secure clients and expand the same-day delivery platform across Canada. Through an API integration with Ample Organics, Pineapple Express Delivery Inc. will have the ability to offer same-day delivery services to all licensed producers which are registered clients of Ample Organics. Namaste remains focused on developing and acquiring leading technology platforms that bring value to the cannabis industry. This Agreement represents a significant milestone for the Company in diversifying its investments in innovative companies, while at the same time having the ability to offer valuable services for its medical patients. Namaste’s goal is to evolve the current landscape for online retail cannabis products by improving the user experience.

Management Commentary

Randy Rolph, President and CEO of Pineapple Express: “We’re very excited to have Namaste as a strategic partner. Our team has extensive experience in implementing same-day delivery platforms across Canada. Our relationship with Namaste and Ample Organics will bring great value to Pineapple Express Delivery Inc. and our growth strategy. Our goal is to offer Canadians with same-day delivery for their medical and recreational cannabis. Our vision and culture is aligned with Namaste’s management team who provide valuable resources to Pineapple Express Delivery Inc. and we’re very much looking forward to a bright future together.”

Sean Dollinger, President and CEO of Namaste comments: “We’d like to thank Randy and his incredible team at Pineapple Express Delivery Inc. for partnering with Namaste in an effort to offer Canadian consumers access to same-day cannabis delivery. In addition, we are extremely excited to welcome Ample Organics as a Pineapple Express Delivery Inc. client, in an effort to reach as many cannabis patients as possible across Canada. Having worked with Ample Organics on separate initiatives, we see the incredible value they are able to bring and are very optimistic that other industry leaders will follow suit, as same-day delivery service becomes a necessity among cannabis users world-wide. Namaste will continue to work in partnership with industry leaders to enhance the overall user experience online and at the same time bring value to the Company and its shareholders. We’re very proud of our partnership with Pineapple Express Delivery Inc. and anticipate a strong demand for their services through Ample Organics’ platform.”

About Pineapple Express Delivery Inc.

Pineapple Express’ management team has over 10 years of experience offering same-day 60-minute delivery services in multiple industries across Canada, and has successfully integrated with Ample Organics Inc., Canada’s leading seed-to-sale medical cannabis software platform. Pineapple Express offers a personalized experience for its customers and has established in depth security and delivery protocols to facilitate same-day delivery of medical cannabis across the country. Pineapple Express is dedicated to providing patients with a fully integrated, simple to use, same-day delivery platform which it believes brings great value to medical patients across the country. For more information visit: www.pineappleexpressdelivery.ca

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer pending receipt of a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

Tags: , , ,
Posted in All Recent Posts, Namaste Technologies Inc. | Comments Off on Namaste $N.ca announces signing of 15% equity acquisition of same-day #cannabis delivery platform, Pineapple Express Delivery Inc. $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Marijuana Company of America $MCOA and Global Hemp Group $GHG.ca Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:40 AM on Wednesday, May 30th, 2018

15233 mcoa

  • Planting of the seeds on the first 77 acres will be completed this week
  • Remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation

Escondido, California–(May 30, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to provide an update on its 125-acre industrial hemp project in northeast New Brunswick with joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG).

The planting of the seeds on the first 77 acres will be completed this week. The remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation.

The Department of Aquaculture Agriculture and Fisheries (DAAF) will also be conducting fertility trials on reserved plots at participating farms. DAAF will contribute the fertilizers to the project as part of these trials. The trials will be conducted at no cost to the project and are a clear indication of the collaborative relationship that has been established with DAAF.

In addition, there is an organic certification trial underway on an additional two-acre plot at the project. It will take three years to complete the organic certification process for this field. As part of the process, the plot will begin a three-year cultivation rotation of hemp, oats and a green manure crop to be defined at a later date. In three years this plot will produce certified organic CBD and organic oats, a crop with an excellent market.

Project managers are currently evaluating drying equipment that will be required to process the biomass after it is harvested. Drying will prepare the biomass for shipment to processors for extraction of the cannabinoids. Management is in discussions with a number of potential processing partners for this material. A final decision will be made in the coming weeks.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tags: , , , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks | Comments Off on Marijuana Company of America $MCOA and Global Hemp Group $GHG.ca Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Namaste $N.ca Closes Acquisition of Leading #A.I. and Machine-Learning Technology Platform Findify.io for $12,000,000 in Cash and Shares $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:21 AM on Tuesday, May 22nd, 2018

Namaste large new

  • Announced that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB
  • Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics

VANCOUVER, May 22, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company“) (TSXV: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB (“Findify” or “Findify.io”), through the purchase of all of the issued and outstanding shares of Findify, for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company. Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics. The acquisition of Findify as a technology platform will bring significant value to Namaste and its shareholders by accelerating the Company’s growth strategy, enhancing conversion rates and revenue and in providing an entry into machine-learning and A.I. for applications for cannabis.

Findify’s Platform and Conversion Rate Optimization

Findify’s platform, which is used by leading e-commerce websites, including Namaste, uses proprietary real-time machine learning algorithms to deliver a truly personalized experience to each and every customer. Through robust data collection, the platform analyzes user behavior and in combination with product trends, it automatically and continuously displays relevant products to each customer at any given time. The ability to deliver accurate and relevant products real-time, leads to increases in revenue, conversion rates and average order value.

Namaste will deploy Findify’s full product suite across its platform in order to bring this intelligence across all consumer touch-points. This focus on conversion rate optimization (CRO) using A.I. and machine learning technology will provide Namaste’s customers and patients, with an enhanced user experience while also increasing sales. The Company’s management team anticipates that the integration of Findify’s full-suite of proprietary technology will increase monetization, deliver a better user experience for customers, and propel revenue growth in both cannabis and hardware sales.

Cannabis A.I.

The Namaste and Findify team are pleased to be bringing the power of artificial intelligence to solve the problem of unpredictability in plant medicine. Findify’s technology will help bring clarity to our consumers and patients, who seek a specific cannabis strain in an ocean of variety, misinformation, uncertainty. Recent studies have revealed that the cannabis plant has 144 cannabinoids and over 100 terpenes, each with beneficial properties in unique combinations, affecting individuals in different ways. In addition to having over a thousand strains and over 200 variations of beneficial compounds, humans have different responses to each of these strains, making it an enormous challenge to find the right strain for the right person and their particular needs. Today, we search for that perfect strain by means of trial & error or guesswork. But Findify’s proprietary machine learning technology will allow us to match each unique individual with the relevant cannabis products for them. The Findify acquisition uniquely positions Namaste to develop a cannabis-focused A.I. platform that will provide a deeper understanding of patients needs and behaviours in an effort to provide a more relevant and personalized experience.

Key terms of the Acquisition:

  • Namaste acquired all issued and outstanding shares of Findify in exchange for:
    • US $2,000,000 in cash, paid upon the closing date of the proposed transaction.
    • US $10,000,000 paid in common shares of Namaste at a mutually agreed price of C$1.80 per common share.

The acquisition of Findify represents a major milestone for Namaste as its largest and first technology-based acquisition. Namaste will roll-out the entire suite of products available through Findify on all touch points in order to bring real-time intelligence across its platform. Findify will also leverage their experience working with 1000+ e-commerce stores, with conversion rate optimization and enhanced UX design.

Management Commentary

Meni Morim, Founder and CEO of Findify comments:

“We are delighted to officially be part of the Namaste Technologies team. We believe that technology can make the world a better place, and we strive to achieve that vision by bringing plant-based holistic medicine to the masses. By leveraging the power of A.I., we can understand complex plant characteristics and match them with patients’ profiles, thus helping patients with ailments such as chronic pain find the right strain of cannabis to alleviate their condition. It’s exciting to be able to use Namaste’s platform to offer people in remote areas access to health professionals and high-quality products.

During the acquisition process, we had the opportunity to work closely with the Namaste management team. It is an incredibly experienced and talented group of people, with drive and dedication which is truly inspiring. We are honored to be part of such a team.

We have spent a significant time reviewing the vision and roadmap of Namaste, and we’re very excited to take part in shaping the future of cannabis. We will be working hard on weaving A.I. into all aspects of the Namaste offering, which will deliver an unparalleled experience to our customers and patients.”

Sean Dollinger, President and CEO of Namaste comments:

“We are very excited to have acquired such an innovative company. Findify’s team have demonstrated themselves to be not only cutting-edge developers but also like-minded in business and strategy. We have already seen the benefits of A.I. and machine-learning in applications of e-commerce and anticipate strong growth in Findify’s existing business, offering this as a service to retailers. Our strategy will be to roll-out the full-suite of Findify’s offering across all Namaste sites with a focus on increasing CRO and in maximizing revenue and profitability. We have devoted ourselves to acquiring and innovating technology for the cannabis industry. We are very excited to have the opportunity to begin testing machine-learning and A.I. applications specifically within the cannabis industry.

In the future, cannabis patients will demand a more personalized online experience, as products and services in the cannabis industry continue to grow exponentially. We remain focused on positioning the company as a global leader in applications of innovative technology within the cannabis industry. We are very proud to have such talented companies and individuals working in partnership with Namaste to enhance a patient’s online buying experience by providing a deeper level personalization that will directly impact the patient’s experience.”

About Findify AB

Findify is a leader in e-commerce machine learning applications, with over 1200 customers in more than 60 countries around the world. Findify has developed a unique machine learning core, that leverages user behaviour, to personalize online experiences in real-time. Findify’s machine learning technology has been proven to deliver up to 27% uplift in conversion rate, and up to 30% uplift in revenue per user.

Findify is an official Shopify Plus Technology Partner, recognized as a “Best-In-Class Solution” for modern, rapidly growing e-Commerce businesses.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Investor Relations

Phone: 561-542-5052 or 250-300-5103

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward-Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

Tags: , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Closes Acquisition of Leading #A.I. and Machine-Learning Technology Platform Findify.io for $12,000,000 in Cash and Shares $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Marijuana Company of America $MCOA and Global Hemp Group Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:46 AM on Tuesday, May 22nd, 2018

15233 mcoa

  • Partners have hired Joan Parker-Duivenvoorden as fulltime project agrologist and field manager for the project
  • Ms. Parker-Duivenvoorden graduated from Guelph University in 1981 with a BSc (Agr) majoring in plant protection.
  • Contracts have now been signed with the initial group of four farmers, who began seeding this season’s 125-acre industrial hemp crop last week
  • A 4,000 sq. ft. facility has now been secured in Bathurst, New Brunswick for the project

Escondido, California–(May 22, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to provide an update on its New Brunswick Hemp Project with joint venture partner, Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) (the “Partners”).

The Partners have hired Joan Parker-Duivenvoorden as fulltime project agrologist and field manager for the project. Ms. Parker-Duivenvoorden graduated from Guelph University in 1981 with a BSc (Agr) majoring in plant protection. She has over 15 years-experience with the Nova Scotia Dept of Agriculture and with the New Brunswick Soil and Crop Improvement Association (“NBSCIA”). While working at the NBSCA, she has developed strong ties in the farming community that will prove to be advantageous as the project expands from the initial group of four farmers to more than fifty farmers as envisioned in coming years. In addition to being responsible for the project locally, she will provide advisory services to participating farmers, will conduct on-farm research projects to properly monitor the behaviour of various hemp varieties in different environments of the region. She will also develop training materials to assist farmers who will join the project in subsequent years. One of the long-term research projects headed by Ms. Parker-Duivenvoorden will be to develop a profitable crop rotation for organic hemp, opening the way for organic CBD.

Contracts have now been signed with the initial group of four farmers, who began seeding this season’s 125-acre industrial hemp crop last week. The farmers participating in the project in 2018 are located throughout the northeastern region of New Brunswick, Canada, making for a good cross section of results for research conducted on the behavior of the crop across that region. The distribution of farms will maximize the demonstration effect and will facilitate the recruitment of additional farmers in the following years. This carefully selected group of farmers will actively participate in addressing the introduction of this new crop across different regions.

A 4,000 sq. ft. facility has now been secured in Bathurst, New Brunswick for the project. The building will be used for biomass storage and to install drying equipment that will be used to process the fresh material. Dried material will be stored at the facility while awaiting further processing by third party processors. Once proper licenses have been acquired for importing and manufacturing finished CBD products, the site may also serve as a distribution center for the hempSMARTTM and Benihemp line of products.

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.

Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tags: , , , ,
Posted in All Recent Posts, Marijuana Company of America | Comments Off on Marijuana Company of America $MCOA and Global Hemp Group Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Marijuana Company of America’s $MCOA Joint Venture Completes set up of 10,000 sq ft. Greenhouse $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:00 AM on Thursday, May 17th, 2018

15233 mcoa

  • Announced that its Washington based Joint Venture with Bougainville Ventures has completed the setup of 10,000 sq. ft. of greenhouse space
  • Greenhouse is pending the completion of inspection, which is the final step needed before commencing cultivation.

ESCONDIDO, Calif., May 17, 2018  – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company“) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its Washington based Joint Venture with Bougainville Ventures, Inc. has completed the setup of 10,000 sq. ft. of greenhouse space. The greenhouse is pending the completion of inspection, which is the final step needed before commencing cultivation.

Marijuana Company of America - Cannabis Greenhouse in Washington State
Marijuana Company of America (MCOA), in a joint venture with Bougainville Ventures, Inc., has erected the first 10,000 square feet of a 30,000-square-foot greenhouse facility for cannabis cultivation in Washington. When fully built out, the facility will have the capacity to house approximately 4,000 marijuana plants.

The first 10,000 of a 30,000 square foot facility has been fully erected and is ready for inspection this week along with the newly installed security system. The construction crew is currently focused on installing the wiring and mounting panels, plugs and switches, the HVAC system and fans. The Company expects that the final inspection of the security and greenhouse construction will be sometime this week. Once the inspection is approved, the tenant grower will be allowed to occupy the space and begin growing.

Donald Steinberg, MCOA CEO said, “As landlords we are looking forward to providing a turnkey property to the first of hopefully many licensed tenants in Washington. Providing a turnkey facility for tenant growers is an ideal cultivation environment for tenants with minimal start-up capital and consistent rental income for MCOA.”

Once the 30,000 sq. ft. facility is fully built-out, it will have the ability to house approximately 4,000 plants.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Bougainville Ventures, Inc.
Bougainville Venture Inc. is in the core business of converting irrigated farmland that was traditionally used to grow marginally profitable feed crops, to greenhouse-equipped farmland used to grow luxury crops with a primary focus on marijuana. Bougainville is an agricultural services company that focuses on providing growers with state-of-the-art computer controlled greenhouses and processing facilities. Bougainville offers fully built out turnkey solutions to licensed tenant-growers and luxury crop growers who will lease the facilities for production and processing. Bougainville does not “touch the plant” and only provides growing infrastructure as a landlord for licensed marijuana growers.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/1536f9c3-55b6-46f1-86df-622bfd2e81ea

Tags: , , ,
Posted in All Recent Posts, Marijuana Company of America | Comments Off on Marijuana Company of America’s $MCOA Joint Venture Completes set up of 10,000 sq ft. Greenhouse $AERO $CBDS $CGRW $APH.ca $GBLX

Marijuana Company of America and Global Hemp Group Provide Update on CBD Farm Joint Venture in Scio, Oregon $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:38 AM on Tuesday, May 15th, 2018

15233 mcoa

  • Provides an update on their CBD hemp farming project in Scio, Oregon
  • Garden operations are well underway at the farm
  • Initial nursery and propagation rooms for clones have recently been expanded to an additional attached greenhouse
  • Team continues to produce clones for planting in the current season

ESCONDIDO, Calif., May 15, 2018  – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA) and joint venture partner Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) (the “Partners”) are pleased to provide an update on their CBD hemp farming project in Scio, Oregon (the “Project”).

Garden operations are well underway at the farm. The initial nursery and propagation rooms for clones have recently been expanded to an additional attached greenhouse as the team continues to produce clones for planting in the current season. In order to maximize planting density, an additional 20,000 high yielding CBD hemp clones are being purchased and will be delivered before the end of May to meet the targeted planting schedule of early June.

Five additional greenhouses have now been purchased for the project. The first two 30ft. x 120ft greenhouses are currently being installed and will provide an additional 7,200 sq. ft. of greenhouse space for the project. The three remaining 42ft x 96ft greenhouses will begin installation before the end of May. When installed, these additional greenhouses will increase greenhouse space by a further 12,096 sq. ft., for a total of 19,296 active greenhouse space.

The team will be planting the clones on the first 35 acres at the farm. They will be planted “orchard style”, 4 to 5 feet on center, with rows 5 feet apart to provide space for each plant to receive sufficient sunlight, water and nutrients, and mature to maximum size to produce the highest CBD yield possible upon harvest.

The Scio farm will employ both traditional outdoor orchard style cultivation and perpetual harvest in greenhouses. The Partners are currently evaluating additional greenhouse technologies for expansion of indoor cultivation space to augment its perpetual harvest model square footage. This dual strategy will optimize revenue generation throughout the year to minimize the impact of single crop harvesting in October when most other hemp CBD farms harvest and typically drive prices down. Market prices tend to climb throughout the year as less biomass is available for processing and distribution, as is occurring with current market prices. Starting in August, it is expected that full spectrum CBD oil will be in tight supply and prices will continue to climb until after the October 2018 harvest season is processed.

The team is in the process of ordering the required equipment to facilitate farm operations from planting through harvesting, drying and storage.

In addition, the Partners are currently evaluating a field analytics software application to be employed for data collection and analysis to optimize farming operations. The software will be used to evaluate the three cultivation methods being employed by the Partners in 2018; high yielding CBD cultivars grown orchard style outdoors in Scio, Oregon, perpetual harvest in greenhouses also at Scio, and traditional dense field cropping with lower yielding CBD cultivars in New Brunswick, Canada.  Results will assist the team in determining optimal yield per acre for future expansion of acreage in both the United States and Canada.

“Our evolving project in Scio, Oregon highlights the quality of the team in place as they continue to lean on their many years of experience cultivating hemp.  Activities such as these will help to secure the raw oil that we will need for our hempSMART brand of CBD infused products,” says Donald Steinberg, CEO of Marijuana Company of America.  See our products at www.hempsmart.com

“The Scio, Oregon high yielding CBD hemp project is something that we have been working on putting together most of this year. It’s great to see that the project is now officially underway, and we look forward to sharing pictures and results of the operation as we go forward,” stated Charlie Larsen, President of Global Hemp Group.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc., is headquartered in Vancouver, BC, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Tags: , , , , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks | Comments Off on Marijuana Company of America and Global Hemp Group Provide Update on CBD Farm Joint Venture in Scio, Oregon $AERO $CBDS $CGRW $APH.ca $GBLX

« Older Entries
Newer Entries »